<DOC>
	<DOC>NCT01887483</DOC>
	<brief_summary>A two month intervention trial assessing the effect of Vetal Laban containing L. acidophilus on enhancing functional bowel wellbeing among subjects with irritable bowel syndrome (IBS).</brief_summary>
	<brief_title>Vetal Laban Intervention Trial Assessing Bowel Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Males and females aged 18 to 65 years Subjects fulfilling Rome III criteria for IBS Sufficient health and orientation for participating in the trial Obtained his/her informed consent after verbal and written information. Have a high probability for compliance with and completion of the study. Body Mass Index (BMI) between 19 and 35. Diagnosed or suspected organic gastrointestinal disease (i.e. colitis, Crohn's disease, celiac disease, major bowel surgery, recurrent diverticulitis) or severely impaired general health including cancer and cancer therapy. Lactose intolerance Unwillingness to refrain from probiotic use during the trial Use of antibiotics within the 3 preceding months prior to recruitment Pregnant, planning pregnancy or lactating Expected major lifestyle changes related to nutrition, exercise, travelling etc. Participation in a clinical trial with an investigational product or drug within 3 months prior to screening. Substance abuse Subjects unable to read and understand the questionnaires</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>IBS</keyword>
	<keyword>bowel function</keyword>
	<keyword>probiotic</keyword>
</DOC>